Difficulty: Medium
Average Score: 87%
Practice
Tick the anticancer alkylating drug, a derivative of chloroethylamine:
Correct answer
C
Rationale
In this question, the correct answer is C) Cyclophosphamide. Cyclophosphamide is an anticancer alkylating drug that is a derivative of chloroethylamine. Alkylating agents work by attaching alkyl groups to DNA, which prevents cell division and ultimately leads to cell death. Cyclophosphamide is commonly used in the treatment of various cancers, including leukemia, lymphoma, and solid tumors.
Now, let's analyze why the other options are incorrect:
A) Methotrexate: Methotrexate is not an alkylating agent. It is a type of antimetabolite drug that inhibits dihydrofolate reductase, interfering with DNA synthesis.
B) Cisplatin: Cisplatin is a platinum-containing compound and not an alkylating agent. It works by forming cross-links in DNA, leading to cell death.
D) Carmustine: Carmustine, also known as BCNU, is a nitrosourea compound and not an alkylating agent. It interferes with DNA replication and RNA transcription.
Educationally, understanding the classification of anticancer drugs based on their mechanisms of action is crucial for pharmacology students and healthcare professionals. Knowing the specific properties of each drug helps in selecting the most appropriate treatment for different types of cancers and understanding potential side effects and interactions. This knowledge is essential for safe and effective medication management in clinical practice.
Now, let's analyze why the other options are incorrect:
A) Methotrexate: Methotrexate is not an alkylating agent. It is a type of antimetabolite drug that inhibits dihydrofolate reductase, interfering with DNA synthesis.
B) Cisplatin: Cisplatin is a platinum-containing compound and not an alkylating agent. It works by forming cross-links in DNA, leading to cell death.
D) Carmustine: Carmustine, also known as BCNU, is a nitrosourea compound and not an alkylating agent. It interferes with DNA replication and RNA transcription.
Educationally, understanding the classification of anticancer drugs based on their mechanisms of action is crucial for pharmacology students and healthcare professionals. Knowing the specific properties of each drug helps in selecting the most appropriate treatment for different types of cancers and understanding potential side effects and interactions. This knowledge is essential for safe and effective medication management in clinical practice.